Cargando…
Nephrotoxicity of Immune Checkpoint Inhibitors: Acute Kidney Injury and Beyond
Immune checkpoint inhibitors (ICIs) are novel humanized monoclonal antibodies that release the brakes on the immune system, resulting in the destruction of tumor cells. ICIs are approved for a variety of hematological and solid organ malignancies, and the list has been growing since the approval of...
Autores principales: | Tinawi, Mohammad, Bastani, Bahar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817088/ https://www.ncbi.nlm.nih.gov/pubmed/33489613 http://dx.doi.org/10.7759/cureus.12204 |
Ejemplares similares
-
Immune checkpoint inhibitor related nephrotoxicity: Advances in clinicopathologic features, noninvasive approaches, and therapeutic strategy and rechallenge
por: Miao, Jing, et al.
Publicado: (2022) -
Case Report: Immune checkpoint inhibitor–induced multiorgan vasculitis successfully treated with rituximab
por: Qureshi, Sehrish, et al.
Publicado: (2023) -
Acute Kidney Injury and Intestinal Dysbiosis
por: Chávez-Iñiguez, Jonathan Samuel, et al.
Publicado: (2022) -
Acute Kidney Injury Caused by Renin-Angiotensin System Inhibitors During Minimal Change Disease Treatment
por: Torigoe, Kenta, et al.
Publicado: (2022) -
Hyperacute Onset of Immune Checkpoint Inhibitor–Related Acute Interstitial Nephritis
por: Tawhari, Ibrahim, et al.
Publicado: (2020)